Skip to content

Clinical evaluation of siddha medicine Muppirandai chooranam for heavy menstrual bleeding.

Phase II non randomized open clinical evaluation of siddha medicine Muppirandai chooranam for pitha perumbadu (Menorrhagia)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047297
Enrollment
40
Registered
2022-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

Intervention1: MUPPIRANDAI CHOORANAM: This Siddha herbal drug will be given as 1 gram, BD dose with honey, for 3 consecutive cycles for the management of Menorrhagia Control Intervention1: not applic

Sponsors

Dr R SHANTHINI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Excessive menstruation (Bleeding - one or more pads or tampons every 2 hours) Prolonged menstruation (Bleeding - lasts longer than eight days)Puberty menstruation Premenopausal menorrhagia Menorrhagia in PCOD Hb level above 8gms

Exclusion criteria

Exclusion criteria: Fibroid polyp Bleeding disorders Hypothyroidism Abortion and pregnancy Ovarian feminizing tumour Adenomyosis Chocolate cyst Uterine fibroids Endometrial cancer Uterine sarcomas

Design outcomes

Primary

MeasureTime frame
Reduced amount of Menstrual blood flow is assessed by number of sanitary pads used before and after treatment by the chart PICTORIAL BLOOD ASSESSMENT CHARTS (PBAC)Timepoint: The outcome will be assessed by reduction in the clinical symptoms for 3 consecutive cycles.

Secondary

MeasureTime frame
Improvement in Hb will be monitoredTimepoint: Improvement of Hb will be monitored in the fourth consecutive cycle.

Countries

India

Contacts

Public ContactDr R SHANTHINI

Government Siddha Medical College

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026